A Phase I Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2015
At a glance
- Drugs Eribulin (Primary) ; Irinotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 21 Dec 2015 Last checked against ClinicalTrials.gov record.
- 21 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Dec 2014 New trial record